Allergy shots, an age-old treatment for allergy sufferers, are getting a shot in the arm from new research. This proven therapy saves money, according to a recent study.
Allergy immunotherapy is the only treatment available that actually changes the immune system, making it possible to prevent the development of new allergies and asthma. According to research by Cheryl Hankin, PhD, BioMedEcon president and chief scientific officer, allergy immunotherapy also significantly reduces healthcare use and costs for prescription medications, outpatient visits, and inpatient stays.
Compared to children with allergies who did not receive allergy immunotherapy, children who received this treatment saved Florida Medicaid, on average, more than $1,000 within the first three months of treatment, and saved the state nearly $6,000 after 18 months. Results were even more compelling for adults. Average savings to Florida Medicaid were about $1,200 after three months of allergy immunotherapy, and exceeded $7,000 after 18 months.
Allergy immunotherapy is a well-established, safe and effective treatment. Allergies and asthma are serious, high cost, debilitating, chronic illnesses. In light of the current U.S. healthcare crisis, these findings strongly suggest that it is in the best public health interest to promote increased access to allergy immunotherapy for patients who suffer from allergies.